ENTITY
CanSino Biologics

CanSino Biologics (6185 HK)

172
Analysis
Health CareChina
CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based tuberculosis vaccines for human use. CanSino Biologics serves customers worldwide.
more
Refresh
30 Aug 2021 11:36

HK Short Interest: Short Increased in Xiaomi, Pop Mart and Cansino

We highlight week-on-week short interest Increased in Xiaomi, Pop Mart and Cansino based on the latest Hong Kong SFC aggregate short interest report.

Logo
126 Views
Share
28 Aug 2021 05:51

Asia Shorts: Shenzhou, Xiaomi, BABA, BYD, Renesas, Shionogi, Freee, Celltrion, LGD, Novatek, Wan Hai

The Insight looks at movements in short interest across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
227 Views
Share
20 Aug 2021 21:18

Asia Shorts: Meituan, Geely, Kuaishou, COLI, Toshiba, Freee, NCSOFT, SK Tel, Yang Ming, Wan Hai, EMC

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
269 Views
Share
08 Aug 2021 07:56

China Healthcare Weekly (Aug.6)

The insight mainly analyzed increasing short-term volatility in healthcare sector by newly released education policy, Nanjing COVID-19 outbreak,...

Logo
264 Views
Share
27 Jun 2021 08:56

China Healthcare Weekly (Jun.25)

This article analyzed the results of 5th national volume-based purchase, the new announcement on the centralized procurement of artificial joints,...

Logo
211 Views
Share
x